Statistics for Medifast (id:9672 MED)
Valuation metrics
Market cap
201.36M
Enterprise value
42.60M
Trailing P/E (ttm)
27.48
Forward P/E
61.37
PEG ratio
61.37
Price/Sales (ttm)
0.30
Price/Book (mrq)
0.95
Enterprise Value/Revenue
0.06
Enterprise Value/EBITDA
1.58
Overview
Shares outstanding
10.94M
Float
9.44M
Shares short
1.65M
% Held by insiders
0.03%
% Held by institutions
0.86%
Average volume (10 days)
193.50K
Average volume (90 days)
Price summary
52-Week low
17.07
52-Week high
76.42
52-Week change
-252.85%
Beta
1.16
50-Day moving average
18.50
200-Day moving average
25.28
Dividends and splits
Forward annual dividend rate
6.60
Forward annual dividend yield
0.36
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
5.69
Payout ratio
0.00
Dividend date
November 07th, 2023
Ex-dividend date
September 18th, 2023
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
1.09%
Operating margin
1.50%
Operational effectiveness
Return on assets
4.77%
Return on equity
3.66%
Income statement
Revenue (ttm)
61.77
Revenue per share (ttm)
61.77
Quarterly revenue growth (yoy)
-0.95
Gross profit (ttm)
775.85M
EBITDA
139.51M
Net income to common (ttm)
7.32M
Diluted EPS (ttm)
0.67
Quarterly earnings growth (yoy)
-95.10%
Balance sheet
Total cash (mrq)
169.96M
Total cash per share (mrq)
15.96
Total debt (mrq)
17.62M
Total Debt/Equity (mrq)
8.50
Current ratio (mrq)
310.80%
Book value per share (mrq)
19.47
Cash flow
Cash flow statement
39.94M
Levered free cash flow (LFCF)
-7,088,125.00